Market Overview

UPDATE: Loewen, Ondaatje, McCutcheon Initiates Cardica at Buy on Competitive Positioning

Related CRDC
Cardica Prices Public Offering of Common Stock and Preferred Stock at $0.85 per Share
Mornings Movers for Feb. 27, 2014: PEIX, JCP, SYMX, CIE, SHLD, BBY Higher, INO, NDLS, HK, CY, DYAX Lower

Loewen, Ondaatje, McCutcheon initiated coverage on Cardica (NASDAQ: CRDC) with a Buy rating and a $2.50 price target.

Loewen, Ondaatje, McCutcheon commented, "Cardica is an exciting turnaround story that will be driven by its recent commercial entry into the $1.6 billion global endoscopic stapler market. The Company's MicroCutter XCHANGE 30 is a unique and highly differentiated surgical instrument that, among several advantages, is substantially smaller than competing products. Based on our clinician and industry due diligence, we believe Cardica is well‐positioned to capture a significant share of the 4 million minimally invasive surgeries performed annually worldwide that utilize an endoscopic stapler."

Cardica closed at $1.10 on Monday.

Latest Ratings for CRDC

Nov 2014Craig-HallumDowngradesBuyHold
May 2013WedbushInitiates Coverage onOutperform
Jan 2013Loewen, Ondaatje, McCutcheonInitiates Coverage onBuy

View More Analyst Ratings for CRDC
View the Latest Analyst Ratings

Posted-In: Loewen McCutcheon OndaatjeAnalyst Color Initiation Intraday Update Analyst Ratings


Related Articles (CRDC)

View Comments and Join the Discussion!